Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Nephros (NEPH) over the last 16 years, with Q3 2025 value amounting to -$85000.0.

  • Nephros' Other Working Capital Changes rose 2272.73% to -$85000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$333000.0, marking a year-over-year increase of 2869.38%. This contributed to the annual value of $11886.0 for FY2024, which is 10347.54% up from last year.
  • As of Q3 2025, Nephros' Other Working Capital Changes stood at -$85000.0, which was up 2272.73% from -$305000.0 recorded in Q2 2025.
  • Nephros' Other Working Capital Changes' 5-year high stood at $137000.0 during Q1 2025, with a 5-year trough of -$305000.0 in Q2 2025.
  • Its 5-year average for Other Working Capital Changes is -$90578.9, with a median of -$89000.0 in 2021.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first crashed by 26250.0% in 2021, then surged by 20960.0% in 2025.
  • Over the past 5 years, Nephros' Other Working Capital Changes (Quarter) stood at -$89000.0 in 2021, then increased by 6.74% to -$83000.0 in 2022, then fell by 26.51% to -$105000.0 in 2023, then rose by 23.81% to -$80000.0 in 2024, then decreased by 6.25% to -$85000.0 in 2025.
  • Its last three reported values are -$85000.0 in Q3 2025, -$305000.0 for Q2 2025, and $137000.0 during Q1 2025.